Key Stats for Axcelis Technologies Stock
- 52-Week Range: $43 to $122
- Current Price: $119
- TIKR Model Target (Dec. 2030): $237
What Happened?
Axcelis Technologies (ACLS), the Beverly, Massachusetts-based maker of ion implantation systems used to embed electrically active atoms into semiconductor wafers, has surged roughly 176% off its 52-week low, with Axcelis Technologies stock now trading near $121.84 at its 52-week high as investors begin pricing in a business inflection the consensus has not yet formalized.
The company posted Q4 2025 revenue of $238.33 million, beating analyst estimates of $215.04 million by 10.8%, while non-GAAP earnings per diluted share of $1.49 cleared the $1.12 consensus by a similarly wide margin.
The beat was anchored by record revenue in CS&I, the customer service and support segment covering upgrades, spare parts, and service contracts, which grew 14% for the full year 2025 and hit a new quarterly record of $82 million in Q4.
The Veeco transaction, under which Axcelis will acquire Veeco Instruments and its thin-film deposition equipment portfolio to build a broader semiconductor process equipment platform, cleared a shareholder vote on February 6 and now awaits final regulatory approval from China’s State Administration for Market Regulation, with closing expected in the second half of 2026.
Management framed 2026 as a trough year, guiding for approximately flat full-year revenue at roughly $839 million, with memory growth led by DRAM capacity additions driven by AI demand expected to offset softness in power and general mature node markets.
Russell Low, President and CEO, stated on the Q4 2025 earnings call that “the integration planning process has reinforced our confidence in the potential of this merger and in our plans to come together as one company to unlock even greater value for all of our stakeholders,” pointing to cultural alignment and complementary technology portfolios as the foundation for post-close compounding.
The silicon carbide upgrade cycle, referring to power semiconductors used in electric vehicles and industrial electrification applications, remains a long-duration driver: Axcelis secured a high-value upgrade order in Q4 where a customer converted 150-millimeter tools to 200-millimeter wafer capacity using the new Purion Power Series+, a transaction type that has barely penetrated the installed base and signals a multi-year upgrade pipeline ahead.
Financials: Axcelis Technologies Stock
Despite an ~18% revenue decline from $1.02 billion in 2024 to $0.84 billion in 2025, ACLS held gross margins at 44.9%, the highest level in the five-year historical record, a result that reflects the deliberate CS&I mix shift toward high-margin upgrades and service contracts rather than lower-margin system shipments.
The resilience in gross profit margins sits in sharp contrast to the operating income compression: Axcelis saw operating income fall 43% from $210 million in 2024 to $120 million in 2025, driven by total operating expenses rising to $260 million even as revenue contracted, because SG&A and R&D investment continued to grow through the cycle as the company funded the Purion H6 development and the Veeco integration planning.
The gross margin story across the full five-year window is what makes the trough argument credible: ACLS expanded gross margins from 43% in 2021 to 45% in 2025 through two full revenue cycles, a peak at $1.13 billion in 2023 and a trough at $0.84 billion in 2025, demonstrating that the CS&I aftermarket model structurally defends profitability even when system shipments fall sharply.
The operating margin compression from a peak of 23.5% in 2023 to 14% in 2025 is the genuine risk in the income statement: total operating expenses have grown from $159 million in 2021 to $260 million in 2025, a 62% increase over four years against revenue that has grown only 27% over the same period, and if revenue remains flat in 2026 as guided, operating leverage will remain absent until a meaningful volume recovery arrives.
What Does the Valuation Model Say?
TIKR’s mid-case model assigns Axcelis Technologies a price target of around $237, underpinned by a 12% EPS CAGR assumption through 2031 that captures both the DRAM-driven volume recovery and Veeco’s contribution to net income margin expansion toward around 21%, nearly 7 percentage points above the trough 2025 level.
A potential 100% return from $118.73, annualizing at around 16% per year over 5.7 years, means that Axcelis Technologies stock is deeply undervalued relative to its multi-year earnings power, particularly given that consensus is anchored entirely to the trough year and has not modeled the combined Veeco platform.
Whether ACLS delivers on the re-rating thesis or stalls near current levels hinges entirely on two variables arriving on schedule: the Veeco close and the DRAM wafer start ramp, both of which management has guided to the back half of 2026.
What Has to Go Right
- DRAM wafer starts at SK Hynix Yongin (four mega-fabs targeting 200,000 wafer starts per week) and competing North American and Korean fabs ramp on schedule, generating the $150 million to $200 million per 100,000 wafer starts in ion implant content that underpins the memory recovery
- China SAMR approves the Veeco merger by the second half of 2026, allowing cross-selling of the Purion and Veeco deposition platforms to shared logic and memory customers and unlocking combined revenue that neither standalone business captures
- The silicon carbide upgrade cycle (150-millimeter to 200-millimeter conversions via Purion Power Series+) deepens penetration into the installed base, with management noting only a small fraction of tools have converted and high-value upgrades generating favorable CS&I margins
- The new North American memory customer, who placed a high-current system order before evaluation completion, expands into a multi-system relationship that reduces ACLS’s Korea revenue concentration ahead of the next DRAM CapEx cycle
What Could Go Wrong
- China SAMR withholds or significantly delays Veeco approval, leaving Axcelis carrying ongoing transaction-related costs with no revenue benefit and resetting the 2026 and 2027 consensus model
- Memory customers prove unable to free cleanroom space at the pace management expects, pushing the DRAM volume ramp beyond 2026 and stranding the flat revenue guide without any offsetting growth driver
- Power and general mature markets take longer to recover than improving utilization rates suggest, with analog and power customers reducing CapEx guidance further on softening auto and industrial end demand
- Tariff impacts on inventory costs exceed the less-than-100-basis-points estimate for the full year, compressing non-GAAP gross margins below the guided low-to-mid-40% range and pressuring EPS further below the consensus of around $3.64
Should You Invest in Axcelis Technologies, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up ACLS stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Axcelis Technologies, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze ACLS stock on TIKR for Free →
